is retatrutide approved 2025 Promises Big Weight Loss, but Safety Remains a Question Who Makes Retatrutide? Company Behind

These ads can be appealing, intrusive, confusing or even misleading, and have sparked widespread concerns about inappropriate use and adverse events

Association of parkinson disease with risk of cardiovascular disease and all-cause mortality, A nationwide Population-Based Cohort Study

Tambin se albergaban grandes esperanzas de que los medicamentos pudieran ayudar a las personas en riesgo de padecer alzhimer, pero, hasta ahora, esa investigacin no ha dado resultados

At a systems level, this work highlights the power of large health-system datasets, like the MHS, to evaluate rare outcomes and support evidence-informed decision-making